β-conglycinin combined with fenofibrate or rosuvastatin have exerted distinct hypocholesterolemic effects in rats

Lipids in Health and Disease

Volumn 11, Issue , 2012, Pages

  Ferreira, Ederlan S ^a   Silva, Maraiza A ^a   Demonte, Aureluce ^a   Neves, Valdir A ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

conglycinin; cholesterol lowering drugs; hypercholesterolemic diet; rats.

Indexed keywords

BETA CONGLYCININ; FENOFIBRATE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; ROSUVASTATIN; SOYBEAN PROTEIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; BETA CONGLYCININ PROTEIN, GLYCINE MAX; BETA-CONGLYCININ PROTEIN, GLYCINE MAX; CHOLESTEROL; FLUOROBENZENE; GLOBULIN; HYPOCHOLESTEROLEMIC AGENT; PLANT ANTIGEN; PYRIMIDINE DERIVATIVE; SEED STORAGE PROTEIN; SULFONAMIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIET; HYPERCHOLESTEROLEMIA; HYPOCHOLESTEROLEMIA; MALE; NONHUMAN; RAT; TRIACYLGLYCEROL BLOOD LEVEL; ANIMAL; BLOOD; DRUG COMBINATION; DRUG EFFECT; DRUG POTENTIATION; HEART; HEART MUSCLE; ISOLATION AND PURIFICATION; LIPID DIET; LIVER; METABOLISM; ORGAN SIZE; PATHOLOGY; PROTEIN INTAKE; SOYBEAN; WISTAR RAT;

ANIMALIA; GLYCINE MAX; RATTUS; RATTUS NORVEGICUS;

ANIMALS; ANTICHOLESTEREMIC AGENTS; ANTIGENS, PLANT; CHOLESTEROL; DIET, HIGH-FAT; DIETARY PROTEINS; DRUG COMBINATIONS; DRUG SYNERGISM; FENOFIBRATE; FLUOROBENZENES; GLOBULINS; HEART; HYPERCHOLESTEROLEMIA; LIVER; MALE; MYOCARDIUM; ORGAN SIZE; PYRIMIDINES; RATS; RATS, WISTAR; SEED STORAGE PROTEINS; SOYBEAN PROTEINS; SOYBEANS; SULFONAMIDES; TRIGLYCERIDES;

EID: 84855735783     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-11-11     Document Type: Article

References (46)

1. Grain legume proteins and nutraceutical properties. Duranti M, Fitoterapia 2006 77 67 82 10.1016/j.fitote.2005.11.008 16406359 (Pubitemid 43220250)
2. Regulation of lipid metabolism by soy protein and its implication in diseases mediated by lipid disorders. Torres N, Torre-Villalvazo I, Tovar AR, J Nut Biochem 2006 17 365 373 10.1016/j.jnutbio.2005.11.005 (Pubitemid 44250959)
3. Nutritional and nutraceutical approaches to dyslipidemia and atherosclerosis prevention; Focus on dietary proteins. Sirtori CR, GAlli C, Anderson JW, Arnoldi A, Atherosclerosis 2009 203 8 17 10.1016/j.atherosclerosis. 2008.06.019 18687434
4. Molecular nutraceutics as a mean to investigate the positive effects of legume seed proteins on human healthy. Scarafoni A, Magni C, Duranti M, Trends Food Sci Technol 2007 18 454 463 10.1016/j.tifs.2007.04.002 (Pubitemid 47176360)
5. Non-soy legume consumption lowers cholesterol levels: A meta-analysis of randomized controlled trials. Bazzano LA, Thompson AM, Tees MT, Nguyen CH, Winham DM, Nutr Metabol Cardiov Dis 2011 21 94 103 10.1016/j.numecd.2009.08.012
6. Low density lipoprotein receptor activity is modulated by soybean globulins in cell culture. Lovati MR, Manzoni C, Corsini A, Granata A, Fumagalli R, Sirtori CR, J Nut 1992 22 1971 1978
7. 7S Globulin from soybean is metabolized in human cell cultures by a specific uptake and degradation system. Lovati MR, Manzoni C, Corsini A, Granata A, Fumagalli R, Sirtori CR, J Nut 1996 126 2831 2842 (Pubitemid 26376621)
8. Soy protein peptides regulate cholesterol homeostasis in Hep G2 cells. Lovati MR, Manzoni C, Pizzagalli A, Castiglioni S, Duranti M, Magni C, J Nut 2000 130 2543 2549
9. Dietetic and hypocholesterolaemic action of black soy peptide in dietary obese rats. Rho SJ, Park SP, Ahn CW, Shin JK, Lee HG, J Sci Food Agric 2007 87 908 913 10.1002/jsfa.2808 (Pubitemid 46570323)
10. Reduction by phytate-reduced soybean conglycinin of plasma triglyceride level of young and adult rats. Aoyama T, Kohno M, Saito T, Fukui K, Takamatsu K, Yamamoto T, Biosc Biotech Biochem 2001 65 1071 1075 10.1271/bbb.65.1071 (Pubitemid 33665960)
11. Isoflavone-free soy protein prepared by column chromatography reduces plasma cholesterol in rats. Fukui K, Tachibana N, Wanezaki S, Tsuzaki S, Takamatsu K, Yamamoto T, Hashimoto Y, Shimoda T, J Agric Food Chem 2002 50 5717 5721 10.1021/jf025642f 12236704
12. Effects of soybean conglycinin on hepatic lipid metabolism and fecal lipid excretion in normal adult rats. Fukui K, Kojima M, Tachibana N, Kohno M, Takamatsu K, Hirotsuka M, Kito M, Biosc Biotech Biochem 2004 68 1153 1155 10.1271/bbb.68.1153 (Pubitemid 39251436)
13. The subunit from soybean 7S globulin lowers plasma lipids and upregulates liver VLDL receptors in rats fed a hypercholesterolemic diet. Duranti M, Lovati MR, Dani V, Barbiroli A, Scarafoni A, Castiglioni S, Ponzone C, Morazzoni P, J Nut 2004 134 1334 1339 (Pubitemid 38720703)
14. -conglycinin (7S) and glycinin (11S) exert a hypocholesterolemic effect comparable to that of fenofibrate in rats fed high-cholesterol diet. Ferreira ES, Silva MA, Demonte A, Neves VA, J Func Foods 2010 2 275 283 10.1016/j.jff.2010.11.001
15. Soy -conglycinin (7S globulin) reduces plasma and liver cholesterol in rats fed hypercholesterolemic diet. Ferreira ES, Silva MA, Demonte A, Neves VA, J Med Food 2011 14 94 100 10.1089/jmf.2009.0204 21138348
16. Soy protein reduces serum cholesterol by both intrinsic and food displacement mechanism. Jenkins DJA, Mirrahimi A, Srichaicul K, Berryman CE, Wang L, Carleton A, Abdulnour S, Sievenpiper JI, Kendall CWC, Kris-Etherton PM, J Nut 2010 140 2302S 2311S 10.3945/jn.110.124958
17. Food and Drug Administration (FDA) Food labeling: health claims; soybean protein and coronary heart disease. Federal register, rules and regulations 1999 64 57700 57733
18. Combination drug-diet therapies for dyslipidemia. Redeout TC, Hrading ST, Marinangeli CPF, Jones PJH, Transl Res 2010 155 220 227 10.1016/j.trsl.2009.12. 005 20403577
19. Non-pharmacological control of plasma cholesterol levels. Poli A, Marangoni F, Paoletti R, Mannarino E, Lupattelli G, Notarbartolo A, Aureli P, Bernini F, Cicero A, Gaddi A, Catapano A, Cricelli C, Gattone M, Marroco W, Porrini M, Stella R, Vanotti A, Volpe M, Volpe R, Cannella C, Pinto A, Del Toma E, La Vecchia C, Tavani A, Manzato E, Ricardi G, Sirtori C, Zambon A, Nut Metabol Cardiov Dis 2008 18 1 S16
20. Combination therapy for combined dyslipidemia. Xydakis AM, Ballantyne CM, Am J Cardiol 2002 90 21K 29K 12467937 (Pubitemid 35440986)
21. Effects of fenofibrate on lipid metabolism in adipose tissue of rats. Ferreira AVM, Parreira GG, Green A, Botion LM, Metabol Clin Experimtl 2006 55 731 735 10.1016/j.metabol.2006.01.020
22. Altered hepatic metabolism of fatty acids in rats fed hypolipidaemic drug, fenofibrate. Yamamoto K, Fukuda N, Zhang L, Sakai T, Pharmacol Res 1996 33 337 342 10.1006/phrs.1996.0046 8971955 (Pubitemid 26413593)
23. Association between risk of myopathy and cholesterol-lowering effect: A comparison of all statins. Kobayashi M, Chisaki I, Narumi K, Hidaka K, Kagawa T, Itagaki S, Hirano T, Iseki K, Life Sci 2008 82 969 975 10.1016/j.lfs.2008.02. 019 18402982
24. Dynamic viscoelastic study on the gelation of 7S globulin from soybeans. Nagano T, Hirotsuka M, Mori H, Kohyama K, Nishinari K, J Agric Food Chem 1992 40 941 944 10.1021/jf00018a004
25. Protein measurement with the folin-phenol reagent. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ, J Biol Chem 1951 193 265 275 14907713
26. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Laemmli UK, Nature 1970 227 680 684 10.1038/227680a0 5432063
27. AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. Reeves PG, Nielsen FH, Fahey GC, J Nut 1993 123 1939 1951 (Pubitemid 23342492)
28. Diet and cholesterolemia. I. Development of a diet for the study of nutritional factors affecting cholesterolemia in the rat. Nath N, Wiener R, Harper AE, Elvehjem CA, J Nut 1959 67 289 307
29. Photometric determination of cholesterol (CHOD-PAP method). Stockbridge H, Hardy RI, Glueck CJ, J Labor Clin Med 1989 114 142 151
30. HDL-cholesterol precipitant. Assmann G, Randox Labs. Ltd. Crumlin Co. Antrim Northern Ireland Internist 1979 20 559
31. Liquid triglycerides (GPO-PAP). Medi Diagnostic Italy. Annoni G, Botasso BM, Ciaci D, Donato MF, Tripodi A, J Labor Clin Med 1982 9 115
32. Hypocholesterolaemic effects of milk-kefir and soyamilk-kefir in cholesterol-fed hamsters. Liu JR, Wang SY, Chen MJ, Chen HL, Yuerh PY, Lin CW, British J Nut 2006 95 939 946 10.1079/BJN20061752 (Pubitemid 43805381)
33. Lipoprotein lipases, ljpoproteins and tissue lipids in rats fed fish oil or coconut oil. Haug A, Hostmark AT, J Nut 1987 117 1011 1017
34. The mechanism of dietary cholesterol effects on lipid metabolism in rats. Wang YM, Zhang B, Xue Y, Li ZJ, Wang JF, Yanagita T, Nut Met Card Res 2010 9 4
35. Fenofibrate prevents and reduces body weight gain and adiposity in diet-induced obese rats. Mancini FP, Lanni A, Sabatino L, Moreno M, Giannino A, Contaldo F, Colantuoni V, Goglia F, FEBS Letter 2001 491 154 158 10.1016/S0014-5793(01)02146-9 (Pubitemid 32172021)
36. Comparison of dietary control and atorvastatin on high fat diet induced hepatic steatosis and hyperlipidemia in rats. Ji G, Shao X, Leng L, Liu P, Jiang Z, Lip Health Dis 2011 10 23 32 10.1186/1476-511X-10-23
37. Decreases in serum triacylglycerol and visceral fat mediated by dietary soybean -conglycinin. Kohono M, Hirotsuka M, Kito M, Matsuzawa Y, J Atheroscl Thromb 2006 13 247 255 10.5551/jat.13.247
38. Soybean -conglycinin diet suppresses serum triglyceride level in normal and genetically obese mice by induction of beta-oxidation, down regulation of fatty acid synthase, and inhibition of triglyceride absorption. Moriyama T, Kishimoto K, Nagai K, Urade R, Ogawa T, Utsumi S, Maruyama N, Maebuchi M, Biosc Biotech Biochem 2004 68 352 359 10.1271/bbb.68.352 (Pubitemid 39251534)
39. Incidence of coronary heart disease and lipoprotein cholesterol levels: the Framingham Study. Castelli WP, Garrison RJ, Wilson PWF, Abbott RD, Kalousdian S, Kannel WB, J Amer Med Assoc 1986 256 2835 2838 10.1001/jama.1986.03380200073024 (Pubitemid 17178361)
40. Changes in lipid metabolism by soy -conglycinin-derived peptides in HepG2 cells. Mochizuki Y, Maebuchi M, Kohno M, Hirotsuka M, Wadahama H, Moryiama T, Kawada T, Urade R, J Agric Food Chem 2009 57 1473 1480 10.1021/jf8031793 19182913
41. Dietary Soy -Conglycinin (7S Globulin) Inhibits Atherosclerosis in Mice. Adams MR, Golden DL, Franke AA, Potter SM, Smith HS, Anthony MS, J Nut 2004 134 511 516 (Pubitemid 38298488)
42. Isolation and identification of peptides from soy 11S-globulin with hypocholesterolemic activity. Pak VV, Koo M, Kasimova TD, Kwon DY, Chem Nat Comp 2005 41 710 714 10.1007/s10600-006-0017-6
43. Soy Protein Affects Serum Insulin and Hepatic SREBP-1 mRNA and Reduces Fatty Liver in Rats. Ascencio C, Torres N, Isoard-Acosta F, Gámez- Pérez F J, Hernández-Pando R, Tovar AR, J Nut 2004 134 522 529 (Pubitemid 38298490)
44. Increasing high-density lipoproteins cholesterol: an update on fenofibrate. Depres JP, Am J Cardiol 2001 88 30N 6N 11788128
45. Meta-analysis of the effects of soy protein intake on serum lipids. Anderson JW, Johnstone BM, Cook-Newel ME, N Engl J Med 1995 333 276 282 10.1056/NEJM199508033330502 7596371
46. Systematic review, meta-analysis and regression randomized controlled trials reporting an association between an intake of circa 25 g soya protein per day and blood cholesterol. Harland JI, Haffner TA, Atherosclerosis 2008 200 13 27 10.1016/j.atherosclerosis.2008.04.006 18534601